Table 4 The differences in the scores of particular immune cells and growth factor TGF-beta in the group of 30 patients with primary DCIS and in 11 patients with primary DCIS without local recurrence
Type of immune cell | Initial scores of immune cells in 30 patients with initial DCIS before recurrence median (range) | Scores of immune cells in 11 patients without recurrence median (range) | p-value |
|---|---|---|---|
CD20+ | 5% (1–30) | 5% (1–15) | 0.942 |
CD 163+ | 1% (0–10) | 1% (0–3) | 0.942 |
CD 138+ | 2% (0–30) | < 1% (0–2)* | < 0.001 |
CD4+ | 1% (0–4) | 0% (0–2) | 0.287 |
CD8+ | 2% (1–10) | 1% (1–10) | 0.717 |
FOXP3+ | 0% (0–3) | 0% (0–1) | 0.513 |
TGF-Beta (percentage of patients with positive reaction) | 30% | 18% | 0.371 |